Trials / Not Yet Recruiting
Not Yet RecruitingNCT07179198
A Study to Evaluate the Safety and Effectiveness of Kytogen Defend in Facial Skin Quality Improvement in Adult Participants
A Prospective, Multicenter, Randomized, No-Treatment-Controlled, Assessor-Blinded, Superiority Clinical Investigation to Evaluate the Safety and Effectiveness of Kytogen Defend in Facial Skin Quality Improvement
- Status
- Not Yet Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 500 (estimated)
- Sponsor
- Sinclair Pharmaceuticals Limited · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
This study was designed to evaluate the efficacy and safety of KIO021, an injectable solution for carboxymethyl chitosan, for temporary improvement of facial skin condition. Designed for forward-looking effectiveness. To achieve this, it is planned that 500 subjects with dry skin and dull complexion on the face will be included in the injection.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | KIO021 | KIO021 is used as a device product for dry skin and dull complexion |
Timeline
- Start date
- 2025-09-22
- Primary completion
- 2026-06-30
- Completion
- 2026-11-30
- First posted
- 2025-09-17
- Last updated
- 2025-09-17
Source: ClinicalTrials.gov record NCT07179198. Inclusion in this directory is not an endorsement.